SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-066966
Filing Date
2018-11-08
Accepted
2018-11-08 16:05:30
Documents
3
Period of Report
2018-11-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-39801_18k.htm 8-K 37851
2 EX-10.1 a18-39801_1ex10d1.htm EX-10.1 76125
3 EX-10.2 a18-39801_1ex10d2.htm EX-10.2 91020
  Complete submission text file 0001104659-18-066966.txt   206231
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Filer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13111 | Film No.: 181169669
SIC: 2834 Pharmaceutical Preparations